deflosis

Introduction to Deflosis

Deflosis is a medication primarily used to treat a condition known as Duchenne muscular dystrophy (DMD) in children aged 5 and older. This condition leads to muscle weakening, and Deflosis helps manage its symptoms.

Composition of Deflosis

The active ingredient in Deflosis is Deflazacort. It works by reducing inflammation and suppressing the immune system. When taken, it converts into an active form that binds to the glucocorticoid receptor in cells, leading to a reduction in inflammatory substances.

Uses of Deflosis

• Treatment of Duchenne muscular dystrophy (DMD) in children aged 5 and older.
• Helps reduce inflammation in the body.
• Suppresses the immune system to manage symptoms of DMD.

Side Effects of Deflosis

Common Side Effects:

• Weight gain
• Increased appetite
• Round face (Cushingoid appearance)
• Upper respiratory infections (common cold)
• Frequent urination
• Nose and throat inflammation
• Excessive hair growth
• Irritability

Serious Side Effects:

• Allergic reactions such as rash, itching, or swelling
• Severe dizziness
• Trouble breathing

Precautions of Deflosis

Deflosis should not be taken by individuals who are allergic to it or any of its ingredients. It should be used with caution during pregnancy and breastfeeding. Stopping Deflosis suddenly can lead to steroid withdrawal syndrome, which includes symptoms like loss of appetite, nausea, vomiting, tiredness, and headache.

How to Take Deflosis

• Take Deflosis once daily by mouth.
• The recommended dose is about 0.9 mg for each kilogram of body weight.
• It can be taken with or without food.
• Avoid taking it with grapefruit juice.

Conclusion of Deflosis

Deflosis is an effective medication for managing Duchenne muscular dystrophy in children. It helps reduce inflammation and suppresses the immune system to alleviate symptoms. However, it is important to be aware of its side effects and take necessary precautions while using it. Always consult with a healthcare provider for personalized advice and guidance.